Department of Pathology, Stony Brook University School of Medicine, Stony Brook, NY 11794-8691, USA.
Mol Immunol. 2011 Dec;49(3):495-503. doi: 10.1016/j.molimm.2011.09.024. Epub 2011 Oct 19.
Factors in physiological fluids that regulate the chemotactic activity of complement activation peptides C5a and C5a des Arg are not well understood. The vitamin D binding protein (DBP) has been shown to significantly enhance chemotaxis to C5a/C5a des Arg. More recently, platelet-derived thrombospondin-1 (TSP-1) has been shown to facilitate the augmentation of C5a-induced chemotaxis by DBP. The objective of this study was to better characterize these chemotactic cofactors and investigate the role that cell surface TSP-1 receptors CD36 and CD47 may play in this process. The chemotactic activity in C-activated normal serum, citrated plasma, DBP-depleted serum or C5 depleted serum was determined for both normal human neutrophils and U937 cell line transfected with the C5a receptor (U937-C5aR). In addition, levels of C5a des Arg, DBP and TSP-1 in these fluids were measured by RIA or ELISA. Results show that there is a clear hierarchy with C5a being the essential primary signal (DBP or TSP-1 will not function in the absence of C5a), DBP the necessary cofactor and TSP-1 a dependent tertiary factor, since it cannot function to enhance chemotaxis to C5a without DBP. Measurement of the C5a-induced intracellular calcium flux confirmed the same hierarchy observed with chemotaxis. Moreover, analysis of bronchoalveolar lavage fluid (BALF) from patients with the adult respiratory distress syndrome (ARDS) demonstrated that C5a-dependent chemotactic activity is significantly decreased after anti-DBP treatment. Finally, results show that TSP-1 utilizes cell surface receptors CD36 and CD47 to augment chemotaxis, but DBP does not bind to TSP-1, CD36 or CD47. The results clearly demonstrate that C5a/C5a des Arg needs both DBP and TSP-1 for maximal chemotactic activity and suggest that the regulation of C5a chemotactic activity in physiological fluids is more complex than previously thought.
生理体液中调节补体激活肽 C5a 和 C5a des Arg 趋化活性的因素尚不清楚。维生素 D 结合蛋白 (DBP) 已被证明可显著增强对 C5a/C5a des Arg 的趋化作用。最近,血小板衍生的血栓调节蛋白-1 (TSP-1) 已被证明可促进 DBP 增强 C5a 诱导的趋化作用。本研究的目的是更好地描述这些趋化性协同因子,并研究细胞表面 TSP-1 受体 CD36 和 CD47 在该过程中可能发挥的作用。通过 RIA 或 ELISA 测定正常血清、柠檬酸盐血浆、DBP 耗尽血清或 C5 耗尽血清中 C 激活的正常人中性粒细胞和转染 C5a 受体的 U937 细胞系 (U937-C5aR) 的趋化活性。此外,还测定了这些体液中的 C5a des Arg、DBP 和 TSP-1 水平。结果表明,存在明显的层次结构,C5a 是必需的初级信号(没有 C5a,DBP 或 TSP-1 将无法发挥作用),DBP 是必需的协同因子,TSP-1 是依赖的三级因子,因为没有 DBP 它不能增强对 C5a 的趋化作用。C5a 诱导的细胞内钙流的测量证实了与趋化作用相同的层次结构。此外,对成人呼吸窘迫综合征 (ARDS) 患者的支气管肺泡灌洗液 (BALF) 的分析表明,抗 DBP 治疗后 C5a 依赖性趋化活性显著降低。最后,结果表明 TSP-1 利用细胞表面受体 CD36 和 CD47 来增强趋化作用,但 DBP 不与 TSP-1、CD36 或 CD47 结合。结果清楚地表明,C5a/C5a des Arg 需要 DBP 和 TSP-1 才能发挥最大的趋化活性,并表明生理体液中 C5a 趋化活性的调节比以前认为的更为复杂。